Filing Details
- Accession Number:
- 0001093557-21-000115
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-16 16:44:57
- Reporting Period:
- 2021-04-15
- Accepted Time:
- 2021-04-16 16:44:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1093557 | Dexcom Inc | DXCM | Surgical & Medical Instruments & Apparatus (3841) | 330857544 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1850141 | R Paul Flynn | 6340 Sequence Drive San Diego CA 92121 | Evp, Global Revenue | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-04-15 | 758 | $400.00 | 12,306 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- On December 11, 2020, Mr. Flynn adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Flynn. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- Included in this number are 12,306 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,916 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,756 of which were granted on March 8, 2019 and shall vest through March 8, 2022.